Hinge Health (HNGE) Revenue & Revenue Breakdown
Hinge Health Revenue Highlights
Latest Revenue (Y)
$587.86M
Latest Revenue (Q)
$212.82M
Main Segment (Y)
Reportable Segment
Hinge Health Revenue by Period
Hinge Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2025-12-31 | $587.86M | 50.58% |
| 2024-12-31 | $390.40M | 33.37% |
| 2023-12-31 | $292.73M | - |
Hinge Health generated $587.86M in revenue during NA 2025, up 50.58% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Hinge Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2026-06-30 | $212.82M | 16.74% |
| 2026-03-31 | $182.31M | 6.78% |
| 2025-12-31 | $170.73M | 10.71% |
| 2025-09-30 | $154.21M | 10.87% |
| 2025-06-30 | $139.10M | 12.33% |
| 2025-03-31 | $123.83M | 5.60% |
| 2024-12-31 | $117.26M | 16.54% |
| 2024-09-30 | $100.61M | 12.01% |
| 2024-06-30 | $89.83M | 8.60% |
| 2024-03-31 | $82.71M | 1.45% |
| 2023-12-31 | $81.52M | 0.21% |
| 2023-09-30 | $81.35M | 16.48% |
| 2023-06-30 | $69.84M | - |
Hinge Health generated $212.82M in revenue during Q2 2026, up 16.74% compared to the previous quarter, and up 171.87% compared to the same period a year ago.
Hinge Health Revenue Breakdown
Hinge Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 25 |
|---|---|
| Reportable Segment | $587.86M |
Latest
Hinge Health's latest annual revenue breakdown by segment (product or service), as of Dec 25: Reportable Segment (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 26 | Mar 26 |
|---|---|---|
| Reportable Segment | $212.82M | $182.31M |
Latest
Hinge Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 26: Reportable Segment (100.00%).
Hinge Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| OSCR | Oscar Health | $11.70B | $4.88B |
| LNTH | Lantheus | $1.54B | $388.18M |
| HNGE | Hinge Health | $587.86M | $212.82M |
| WGS | GeneDx | $427.54M | $114.44M |
| CRNX | Crinetics Pharmaceuticals | $5.42M | $25.12M |
| AKRO | Akero Therapeutics | - | - |
| VKTX | Viking Therapeutics | - | - |
| IMVT | Immunovant | - | $7.09M |
| DYN | Dyne Therapeutics | - | - |
| PRAX | Praxis Precision Medicines | - | - |